Influence of Stroke Clinical Pathway on Documentation by Sternberg, Shannon
Clemson University
TigerPrints
All Theses Theses
12-2007
Influence of Stroke Clinical Pathway on
Documentation
Shannon Sternberg
Clemson University, ssternberg@ghs.org
Follow this and additional works at: https://tigerprints.clemson.edu/all_theses
Part of the Nursing Commons
This Thesis is brought to you for free and open access by the Theses at TigerPrints. It has been accepted for inclusion in All Theses by an authorized
administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.
Recommended Citation
Sternberg, Shannon, "Influence of Stroke Clinical Pathway on Documentation" (2007). All Theses. 243.
https://tigerprints.clemson.edu/all_theses/243
  
 
 
 
 
INFLUENCE OF STROKE CLINICAL PATHWAY ON DOCUMENTATION 
 
 
A Thesis 
Presented to 
the Graduate School of 
Clemson University 
 
 
In Partial Fulfillment 
of the Requirements for the Degree 
Master of Science 
Nursing 
 
 
by 
Shannon Sternberg, BSN, RN, CNRN 
December 2007 
 
 
Accepted by: 
Linda Howe, PhD, APRN, CNE, Committee Chair 
Julie Eggert, PhD, GNP-C, AOCN 
Dawn W. Blackhurst, DrPH 
Cynthia Trout, MSN, RN, CRRN
ABSTRACT 
 
The purpose of this study was to determine whether the implementation of 
a stroke clinical pathway could improve compliance with documentation of 
specific quality measures for patients admitted with the diagnosis of acute 
ischemic stroke, hemorrhagic stroke, or transient ischemic attack. The study 
used the ten standardized performance measures for stroke identified by the 
Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and 
integrated documentation of those measures into a stroke clinical pathway 
consisting of physician order sets, an interdisciplinary plan of care, and a 
patient/family education flow sheet. The American Stroke Association’s Get with 
the Guidelines – Stroke (GWTG-Stroke) database was used to collect data 
retrospectively on 220 patient records.  The control group consisted of 110 
randomly selected records of patients admitted with stroke in the year prior to 
clinical pathway implementation. The intervention group consisted of 110 
consecutive records for patients discharged with a stroke diagnosis six months 
after clinical pathway implementation.  Six data collectors reviewed the records to 
gather the information. Records were entered into the database by a single 
researcher. A pre-defined measure report was prepared for the “JCAHO Pilot-10” 
from the GWTG-Stroke database. Comparison of the control and intervention 
groups using the Fisher’s Exact test and 95% confidence intervals revealed 
statistically significantly higher rates of compliance with the patient/family stroke 
education (p<0.001) and smoking cessation counseling (p<0.001) measures after 
ii 
pathway implementation. Further analysis of the intervention group was done to 
determine if the use of the clinical pathway forms increased documentation 
compliance with the measures. There was a statistically significant improvement 
in documentation of the measures for the lipid profile (p=0.003) and patient/family 
stroke education (p<0.001) measures when at least one form in the clinical 
pathway was used. A Chi-square test for linear trend indicated there was a 
statistically significant increase in the number of measures met as the usage of 
the clinical pathway increased (p<0.001). This study suggests that 
implementation of a stroke clinical pathway can improve compliance with 
documentation of specific performance measures by members of the healthcare 
team. 
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 CHAPTER I 
INTRODUCTION 
Stroke is the third leading cause of death in the United States and is the 
leading cause of long-term disability.  The prevalence of stroke in 2003 was 2.6% 
or over five million Americans. About 700,000 of these Americans experienced a 
new stroke or a recurrent stroke. About one of every 15 deaths in 2003 could be 
attributed to stroke. Death within the first 30 days following stroke occurred in 8-
12% of ischemic stroke victims and 37-38% of hemorrhagic stroke victims. A 
transient ischemic attack (TIA) preceded approximately 15% of all strokes. The 
estimated cost for stroke care in 2006 was $57.9 billion (Thom et al., 2006).  
South Carolina, with its high rate of stroke mortality, is considered part of 
the “stroke belt” in the southeastern region of the United States (South Carolina 
Department of Health and Environmental Control, 2006). In 2004, stroke was 
listed as the fifth most common reason for inpatient hospitalization in South 
Carolina for individuals 65 years and older (South Carolina Office of Research & 
Statistics, 2005). 
A stroke results from the disruption of blood flow through the cerebral 
arteries to the brain. The resultant injury, as brain cells die from lack of blood flow 
and oxygen, can be devastating and life altering. Ischemic stroke accounts for 
88% of all strokes and occurs due to a blockage in a cerebral blood vessel 
(Thom et al., 2006). This blockage may be due to plaque or blood clot formation 
within the vessel itself. A blockage may also occur when a plaque or clot 
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detaches from the inner wall of a blood vessel or is created within the heart and 
migrates to a small vessel in the brain where it lodges. Transient ischemic 
attacks (TIA) occur from the same mechanism, but the resultant neurologic deficit 
is temporary (American Heart Association, Heart and Stroke Facts, 2003).  A 
focal neurological deficit lasting less than 24 hours has classically been 
considered a TIA. The current trend is to consider stroke symptoms a TIA if they 
last for less than one hour (Sacco et al., 2006). Hemorrhagic strokes account for 
the remaining 12% of strokes (Thom et al., 2006). Since most strokes are 
ischemic, recommendations and guidelines for stroke prevention in adults are 
primarily directed toward risk factors related to this type of event. Emerging new 
therapies for treatment of acute ischemic stroke have raised public and health 
care provider’s consciousness. Stroke awareness has since increased across the 
nation as well as within the “stroke belt”. 
Many guidelines for the management and prevention of stroke, which 
have been published and periodically updated, have set a standard of care for 
this population (Coull et al., 2002; Adams, Adams, Brott, et al., 2003; Adams, 
Adams, Del Zoppo, & Goldstein, 2005; Adams, Del Zoppo, et al., 2007; 
Broderick, et al., 2007; Duncan et al., 2005; Sacco et al., 2006; Wolf et al., 1999). 
These documents reflect the move toward evidence-based practice in this 
country and are intended to assist practitioners in making informed decisions 
about disease management (American Heart Association, Stroke Council 
Guideline Development Manual, 2006).  Yet, the existence of practice guidelines 
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alone does not ensure the integration of recommendations into practice by 
physicians, nurses and other members of the multidisciplinary team.  
Hospitals primarily carry the burden of cost for acute stroke care and 
therefore seek strategies for effectively implementing guidelines. The hospital’s 
goal is to reduce their cost of stroke care through elimination of unnecessary 
tests, procedures, and treatments, while focusing on interventions that are shown 
to be more effective for prevention of complications and improvement of 
outcomes for the stroke population.  
Ten disease-specific care performance measures for stroke were 
identified and detailed by Joint Commission on Accreditation of Healthcare 
Organizations (JCAHO) in its Disease-Specific Care Certification Program: 
Stroke Performance Measurement Implementation Guide (2004) (Table 1). 
Inclusion of prompts for ordering and/or documentation of each of those ten 
measures into a comprehensive stroke clinical pathway may improve the 
incorporation of stroke guidelines into clinical practice. 
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Table 1.  JCAHO Disease-Specific Care Performance Measures for Stroke 
Set Measure Name 
DSC Stroke-1 Deep vein thrombosis prophylaxis  
DSC Stroke-2 Discharged on antithrombotics 
DSC Stroke-3 Patients with atrial fibrillation receiving anticoagulation therapy 
DSC Stroke-4A Tissue plasminogen activator (t-PA) considered 
DSC Stroke-4B Tissue plasminogen activator (t-PA) administered 
DSC Stroke-5 Antithrombotic medication within 48 hours of hospitalization 
DSC Stroke-6 Lipid profile 
DSC Stroke-7 Screen for dysphagia 
DSC Stroke-8 Stroke education 
DSC Stroke-9 Smoking cessation 
DSC Stroke-10 A plan for rehabilitation was considered 
Source: JCAHO Disease-Specific Care Certification Program: Stroke Performance 
Measurement Implementation Guide (2004). 
 
Documentation by the multidisciplinary team of physicians, nurses, 
therapists, and others in the patient medical record provides evidence of 
incorporation of guidelines into practice. Review of the medical record to 
determine compliance with identified measure criteria offers an opportunity for 
hospitals to identify areas for process improvement in the care of stroke patients. 
Use of standardized order sets or clinical pathways is a JCAHO expectation for 
hospitals that seek recognition for excellent stroke patient care (JCAHO, 
Disease-Specific Care Toolkit, 2006). The incorporation of such forms, which 
follow key practice guidelines, utilize existing documentation processes, and are 
readily accessible to all care providers has the potential to positively alter stroke 
care.  
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Statement of the Problem 
The incorporation of elements of the current guidelines into the care and 
management of acute stroke patients continues to be a challenge for many 
hospitals. Specific performance measures for stroke have been identified and 
developed by JCAHO to assist hospitals who are committed to assessing and 
improving the processes and quality of stroke care (JCAHO, Performance 
Measurement Implementation Guide, 2004). Standardized order sets, clinical 
pathways, and nursing care plans are tools that have been utilized by institutions 
to meet this goal in the past. Historically, forms such as these have not 
consistently proven effective in changing practice as defined by decreased length 
of stay and controlled acute care inpatient cost for stroke patients in this 
southeastern academic hospital, the site for this study.  
Purpose of Study 
 The purpose of this study is to determine whether the implementation of a 
stroke clinical pathway can improve the documentation of the ten JCAHO 
disease-specific measures. Clinical pathways are widely accepted as instruments 
that aid in the care of patients with a specific disease process, but can be difficult 
to introduce into an organization if a significant change in behavior is required of 
the users. By tailoring a clinical pathway to current processes in an organization, 
use of the documents may increase. Increased utilization of the stroke clinical 
pathway would then be expected to increase compliance with the ten measures. 
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Hypothesis 
 Written care protocols such as clinical pathways for the evaluation and 
workup of acute ischemic stroke, hemorrhagic stroke, and TIA patients are a 
JCAHO disease-specific care expectation (JCAHO, Disease-Specific Care 
Toolkit, 2006). The ten JCAHO disease-specific measures for stroke were 
identified as evidence-based performance indicators that could improve quality of 
care (JCAHO, Performance Measurement Implementation Guide, 2004). 
Tracking of compliance with these measures offers hospitals an opportunity to 
identify areas for improvement and strategies to affect patient outcomes. 
Therefore the following hypothesis is proposed: 
• The use of a stroke clinical pathway will increase compliance with 
documentation in the medical record of the ten JCAHO disease-
specific performance measures. 
Definitions 
 The stroke clinical pathway consisted of five separate documents. Those 
documents included standardized physician order sets for the emergency 
department (Appendix A), inpatient admission (Appendix B), and discharge 
(Appendix C), as well as the multidisciplinary forms for documentation of the 
patient plan of care (Appendix D) and patient/family education flow sheet 
(Appendix E). The patient/family education flow sheet references the 
patient/family education handbook which covers each of the topics that should be 
discussed with stroke patients and their families (JCAHO, Performance 
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Measurement Implementation Guide, 2004). Table 2 lists each of the forms 
included in the stroke clinical pathway and denote which of the ten JCAHO 
disease-specific measures are addressed by each form. 
Table 2.   Stroke Clinical Pathway Forms with JCAHO Disease-Specific 
Measures 
DSC 
Stroke 
Measure 
Emergency 
Orders 
Inpatient 
Admission 
Orders 
Discharge 
Orders 
Inter-
disciplinary 
Plan of Care 
Interdisciplinary 
Patient/Family 
Education Flow 
Sheet 
1  X  X  
2   X X  
3  X  X  
4A & 4B X X    
5  X  X  
6  X    
7  X  X  
8  X X X X 
9  X X X X 
10  X X X  
 
 The ICD-9-CM Principle Diagnosis Codes for ischemic stroke, 
hemorrhagic stroke, and TIA were used to select patient records for review. The 
ICD-9-CM stroke codes are listed in Table 3 and the diagnoses for which each of 
the ten measures applies are listed in Table 4.  
Table 3.  ICD-9-CM Principal Diagnosis Codes for Stroke 
  Ischemic Stroke 
433.01 Occlusion and stenosis of basilar artery with cerebral infarction 
433.11 Occlusion and stenosis of carotid artery with cerebral infarction 
433.21 Occlusion and stenosis of vertebral artery with cerebral infarction 
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433.31 Occlusion and stenosis of multiple and bilateral precerebral arteries with cerebral infarction 
433.81 Occlusion and stenosis of other specified precerebral artery with cerebral infarction 
433.91 Occlusion and stenosis of unspecified precerebral artery with cerebral infarction 
434.00 Cerebral thrombosis without mention of cerebral infarction 
434.01 Cerebral thrombosis with cerebral infarction 
434.11 Cerebral embolism with cerebral infarction 
434.91 Cerebral artery occlusion unspecified with cerebral infarction 
436 Acute, but ill-defined, cerebrovascular disease 
Hemorrhagic Stroke  
430 Subarachnoid hemorrhage 
431 Intracerebral hemorrhage 
432 Other and unspecified intracranial hemorrhage 
432.0 Non-traumatic extradural hemorrhage 
432.1 Subdural hemorrhage 
432.9 Unspecified intracranial hemorrhage 
TIA 
435.0 Basilar artery syndrome 
435.1 Vertebral artery syndrome 
435.2 Subclavian steal syndrome 
435.3 Vertebrobasilar artery syndrome 
435.8 Other specified transient cerebral ischemias 
435.9 Unspecified transient cerebral ischemias 
Source: JCAHO Disease-Specific Care Certification Program: Stroke Performance 
Measurement Implementation Guide (2004) 
 
Table 4.   Diagnostic Groups for the JCAHO Pilot-10 Disease-Specific 
Measures 
DSC Stroke 
Measure Ischemic Hemorrhagic TIA  
1 X    
8 
 2 X  X  
3 X    
4A & 4B X    
5 X  X  
6 X  X  
7 X X   
8 X X X  
9 X X X  
10 X X   
Source: JCAHO Disease-Specific Care Certification Program: Stroke Performance 
Measurement Implementation Guide (2004) 
  Anticoagulation therapy included the use of warfarin, heparin or 
heparinoids, or other full-dose anticoagulants. Antithrombotic therapy included 
the use of aspirin, aspirin/dipyridamole, warfarin, clopidogril, ticlodipine, 
unfractionated intravenous heparin, and full dose low molecular-weight heparin. 
Thrombolytic therapy included the use of intravenous or intra-arterial 
recombinant tissue plasminogen activator (t-PA). Screenings for dysphagia 
included documentation of a simple water swallow test or neurological evaluation 
specific to swallowing. Stroke education consisted of documentation of patient or 
family education related to type of stroke, complications, and secondary 
prevention. Smoking cessation counseling included documentation that 
information was provided to the patient in addition to advising the patient that 
smoking is bad for their health (JCAHO, Performance Measurement 
Implementation Guide, 2004; Stroke Coding Instructions v7.2, 2006). 
Conceptual Framework 
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Lewin’s Force-Field Model of change describes change as occurring when 
there is an alteration in the equilibrium of a situation. The change process 
consists of three stages. First is “unfreezing” of the status quo, second is 
”moving” to a new level of equilibrium, and third is a “refreezing” to the new state 
of change (Sullivan & Decker, 2005). Lewin’s model considers the balance of two 
types of forces as being responsible for the change process. Those forces are 
either driving or restraining forces. The driving force is one that is either away 
from a negative or towards a positive situation. The effect of a driving force leads 
to locomotion or movement toward change. Obstacles to locomotion due to the 
driving force are called restraining forces. Restraining forces do not lead to 
locomotion, but influence the effect of the driving forces (Lewin, 1997).  In order 
to create change, there must be an alteration in the number or degree of 
restraining forces and/or driving forces. Once those forces are understood, a 
deliberate alteration can result in change. This alteration in forces is the 
unfreezing process; the change or movement to the new goal can then take 
place. After the change has occurred, a refreezing of the forces in the new 
position holds the change in place. A conceptual model of Lewin’s theory is 
depicted in Figure 1. 
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Figure 1.  Lewin’s Force-Field Model of Change. 
 
Present  level of 
equilibrium 
(status quo) 
Driving 
Forces 
Restraining 
Forces 
Unfreezing 
requires a change 
degree or number 
of driving vs. 
restraining forces 
Addition of 
Driving 
Forces 
Removal of 
Restraining 
Forces 
Movement occurs 
as driving forces 
overcome 
restraining forces 
New 
Restraining 
Forces 
New Driving 
Forces 
Refreezing in the 
new state of 
equilibrium occurs 
until the change 
process occurs 
again. 
Adapted from Effective Leadership & Management in Nursing, 6th ed by Eleanor Sullivan & 
Phillip Decker and Field Theory in Social Science by Kurt Lewin. 
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Change in a large organization, such as a hospital, is difficult to create 
since restraining forces for change are many, varied, and sometimes not readily 
apparent due to the complexity of their nature. Some restraining forces to change 
in a hospital environment include healthcare personnel resistance to change, 
limited access to learning opportunities or resources that may provoke change, 
lack of institutional support for change and, lack of resources to initiate change. 
Recent changes in driving forces at the hospital for this study include a renewed 
and collective commitment by hospital leadership to improve stroke care. That 
commitment is due in part to the newly developed JCAHO Primary Stroke Center 
certification program. Acknowledgment and support by leadership of the need to 
unfreeze the current state of equilibrium related to stroke care is essential to 
removing or reducing restraining forces and adding or strengthening driving 
forces. The hospital made a commitment to add driving forces such as a 
physician champion for stroke care, a stroke nurse coordinator, and program 
oversight by a designated director of nursing. Reduction in restraining forces was 
planned to evolve as staff are provided opportunities and resources to integrate 
new guidelines for stroke care into their practice.  
As an initial step in the change process to reduce restraining forces, an 
educational event in the form of a workshop was presented (Appendix F). The 
target audience for this workshop was staff from inpatient, rehabilitation and 
home health nursing as well as physical therapy, occupational therapy, speech 
therapy, and emergency response personnel. This workshop introduced the 
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recently published acute stroke guidelines and the planned implementation of the 
stroke clinical pathway. Implementation of the stroke clinical pathway required 
addition of driving forces and is intended to reduce restraining forces by making it 
easier for practitioners to meet the new standards of care for stroke. Other efforts 
to induce alterations in the forces included presentations of the clinical pathway 
by the stroke physician champion to other physician groups involved in the care 
of stroke patients. The hospital marketing department supplemented the 
presentations by sending informational mailings to those same physician groups.  
The implementation of a comprehensive clinical pathway for stroke is one 
component of a hospital-supported stroke initiative and a tangible step in the 
change process. If successful change occurs, as demonstrated by improved 
documentation of disease-specific measures for stroke, and the hospital moves 
to a new state of change, the next step is to refreeze in order to hold any gains in 
improvement of stroke measures. Measurement of compliance with quality 
indicator documentation is necessary to maintain positive changes and alter 
forces to further improve stroke quality of care.  
Justification for the Study 
 Evaluation of compliance with disease-specific measures for stroke will 
enable the hospital to identify areas where practice guidelines and evidence-
based practice can be better integrated into clinical practice by the 
multidisciplinary team. Any effect of a clinical pathway in consideration and 
13 
documentation of those measures will influence future decisions about process 
improvement opportunities.  
 
14 
CHAPTER II 
 
LITERATURE REVIEW 
 
 The purpose of this chapter is to provide a review of current literature 
related to practice guidelines, JCAHO Disease-Specific Care certification for 
stroke, and clinical pathways. A description of how the literature influenced the 
creation of the stroke clinical pathway for this study follows. 
Practice Guidelines 
 Evidence-based medicine emerged in the 1990’s to help clinicians make 
treatment decisions based on current medical research. The use of evidence-
based medicine is intended to improve patient care and outcomes by providing 
the clinician with more information about a disease state than may be gained 
through experience and formal training (Evidence-Based Medicine Working 
Group, 1992). It is through review of current research that practice guidelines are 
formulated and agreed upon by a consensus of clinical experts (Guyatt, Sinclair, 
Cook, & Glasziou, 1999). Practice guidelines therefore represent a standard of 
care for management of a particular disease state. The American Heart 
Association (AHA) developed a working definition of disease management in 
2004. The expert panel defined disease management as “multidisciplinary efforts 
to improve the quality and cost-effectiveness of care for selected patients 
suffering from chronic conditions” (Faxon, et al., 2004, p 1528). Disease 
management programs should be based on scientifically derived and peer-
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reviewed guidelines from which specific performance measures are identified to 
aid the evaluation of those programs (Faxon, et al., 2004).   
 A movement toward evidence-based practice in nursing has also arisen in 
recent years. As nurse leaders evaluate standards for practice, more emphasis is 
beginning to be placed on interventions that are based on research and quality 
outcomes rather than tradition (Milton, 2007; Penz & Bassendowski, 2006; 
Melnyk, et al., 2004; Deaton, 2001). The concept of evidence-based practice in 
nursing may be considered the gold standard, and its adoption is evidenced by a 
trend toward hospital policy and procedure manuals that are based on available 
research. The integration of evidence-based guidelines into nursing practice can 
be challenging since nurses who deliver care at the bedside may not be prepared 
with the skills or the resources to do so (Springer, Corbett, & Davis, 2006).  
Strategies for introducing clinical guidelines into nursing practice include general 
dissemination of the information in nursing journals, targeting specific groups of 
nurses whose practice may be affected by the guidelines, and providing 
educational interventions to selected groups of nurses. To encourage 
implementation of practice guidelines, strategies could include providing 
reminders and making the guidelines readily accessible to the targeted nurses. 
Inclusion of the guidelines in the form of prompts into existing systems of 
required documentation would also be useful (Craig & Smyth, 2002).  
The American Stroke Association (ASA) published a new set of guidelines 
in 2003 for the management of acute ischemic stroke patients. These guidelines 
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were intended to assist physicians in primary care, emergency medicine, 
neurology, and other disciplines involved to make informed decisions about the 
acute management of stroke victims (Adams, Adams, Brottt, et al., 2003). 
JCAHO used guidelines and scientific statements for stroke management to 
develop ten disease-specific measures for stroke.  The ASA published an update 
to its acute stroke management guidelines in 2007, with the intention of future 
updates every three years (Adams, Del Zoppo, et al.). Many of the 
recommendations are unchanged from the 2003 publication, but there were 
some substantial additions. One such addition includes a strong recommendation 
for the creation of primary stroke centers that are certified through an external 
body such as JCAHO (Adams, Del Zoppo, et al., 2007).   
The Centers for Medicare & Medicaid Services (CMS) initiated a Hospital 
Quality Initiative (HQI) program to address the burden of select disease states on 
America. The purpose of the program is to promote informed decision making by 
consumers about healthcare choices, provide incentives to hospitals that improve 
patient care, and support public accountability for that care (Centers for Medicare 
& Medicaid Services, 2005). The measures chosen for comparison by CMS are 
derived from current medical research and are factors likely to positively impact 
patient outcomes. CMS has worked in collaboration and support with various 
other entities interested in improving patient outcomes including JCAHO. 
Although stroke is not presently a disease state measured by CMS through the 
17 
HQI program, the same method of reporting HQI indicators for improving and 
measuring quality of care should be applied. 
The ASA recognizes there are significant obstacles to consistently 
integrating scientific advances into clinical practice (Schwamm, Pancioli, et al., 
2005).  Making sure that practice guidelines actually guide clinical practice 
requires educating the clinician about the existence of and value to patient care 
of such recommendations. Once the clinician is knowledgeable about standards 
of care for the diagnosis and treatment of a specific disease process, it is 
reasonable to infer that clinical practice will also be affected. A clinical pathway 
for stroke could act as an educational tool to guide those clinicians unfamiliar 
with current standards of care. If clinical practice were affected by the 
incorporation of stroke guidelines, documentation in the medical record would 
reflect the change. It is through the documentation of medical care and the 
decision-making process that hospitals are able to demonstrate the quality of 
care provided. 
In 2004, the Canadian Stroke Quality of Care Study proposed a core set 
of performance indicators for stroke that is similar in nature to the 
recommendations from the ASA (Lindsay, Kapral, Holloway, et al., 2005; 
Lindsay, Kapral, Gladstone, et al., 2005).  In a separate publication, the core 
performance indicators for stroke were compared to the best-practice guidelines 
for nurses published jointly by the Heart and Stroke Foundation of Ontario and 
the Registered Nurses’ Association of Ontario. A few examples of the role of 
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nursing in meeting those measures include the safe and timely administration of 
medications, monitoring and acting to prevent potential complications of medical 
therapy, and educating the patient about risk factor modification. The comparison 
demonstrated a role for nursing in the improvement of performance measures for 
the acute stroke patient (Lindsay, Kelloway, & McConnell, 2005). Nurses in the 
United States share the same role in meeting the disease-specific measures set 
by the JCAHO for stroke center certification. 
 Documentation is an indirect measure of integration of guidelines into 
patient care. The patient medical record should confirm if disease-specific quality 
measures are met or identify patient-specific contraindications. Development of 
quality measures and auditing for compliance with those measures enables a 
hospital to identify the level of medical care provided and take action as 
necessary to improve that care (Walter, Davidowitz, Heineken, & Covinsky, 
2004). 
JCAHO Primary Stroke Center Certification 
JCAHO offers a Disease-Specific Certification Program for stroke to 
hospitals seeking to improve quality, decrease disability, and control costs 
related to stroke care while working toward designation as a JCAHO certified 
Primary Stroke Center. A Primary Stroke Center must incorporate current 
guidelines and recommendations from the ASA and other sources of authority on 
stroke care into its framework. The certification guide addresses factors related 
to the diagnosis and treatment of patients experiencing acute ischemic stroke, 
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hemorrhagic stroke, and TIA. Hospitals are required to report performance 
measures for these three diagnoses to obtain JCAHO Primary Stroke Center 
certification (JCAHO, Performance Measurement Implementation Guide, 2004).  
Based on review of the literature, JCAHO developed a set of ten 
performance measures judged to influence patient outcomes (Table 1). A data 
collection tool (Appendix G) for tracking the ten measures and other performance 
indicators is also provided by JCAHO (JCAHO, Performance Measurement 
Implementation Guide, 2004). While JCAHO has not yet made changes to the 
Stroke Performance Measurement Implementation Guide based on the updated 
ASA recommendations for 2007, it is expected that they will do so in the near 
future. 
In an effort to help hospitals assess compliance with disease-specific 
performance measures, the AHA developed data management tools for coronary 
artery disease, heart failure and stroke. Get with the Guidelines – Stroke 
(GWTG-Stroke) is an instrument designed to aid in the collection of the ten 
JCAHO disease-specific measures. It is also used to collect critical time 
measures in the initial presentation and treatment of acute stroke. It uses the 
same criteria for measurement provided by JCAHO, but uses reminders about 
missing data, deviation from guidelines, and has patient education materials that 
can be printed on demand. When GWTG-Stroke is used, either concurrently or 
retrospectively, it can assist with identification of deviations from current 
guidelines and assessment of variances to a stroke clinical pathway. 
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Early studies using the GWTG-Stroke instrument suggested an 
association in improvement of at least four of the JCAHO stroke measures 
(antithrombotic administration, anticoagulation for atrial fibrillation, lipid 
measurement, and smoking cessation counseling) when it was used to 
concurrently collect data in the hospital setting (LaBresh, et al., 2005).  
Compliance with measurements for the acute interventions of administration of 
antithrombotics and intravenous thrombolytics also increased in hospitals using 
GWTG-Stroke.  By the end of the fourth quarter of use at 99 hospitals utilizing 
GWTG-Stroke, evidence of physician consideration of thrombolytic therapy was 
present for all but 15% of acute stroke patients (Schwamm, LaBresh, et al., 
2005).   
Clinical Pathways
Although there is no single model of a clinical pathway, many are 
comprised of a document for physician ordering and nurse charting. A clinical 
pathway should set expectations for a typical course of care from admission to 
discharge, require education for patients and families, decrease unnecessary 
utilization of resources by discouraging unnecessary tests and procedures, 
provide a system for monitoring patient outcomes, and eliminate duplication 
(Guinane, 1997). Documents for a clinical pathway may include patient care 
plans with discipline-specific responsibilities and interventions, while also 
dictating the timing of services provided. Other documents may include research-
based protocols for reference, standardized physician order sets, documentation 
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forms, and checklists (Lanska, 1998).  A key element to a successful clinical 
pathway is integration of the tool into the existing documentation processes 
within a facility. Streamlining the documentation process reduces the perception 
of additional work and increases use of a clinical pathway (Guinane, 1997). 
In an effort to guide clinical practice so that it conforms more closely to 
current medical evidence, controls healthcare cost, and improves patient 
outcomes, hospitals have often utilized clinical pathways. Population-specific 
clinical pathways became popular in the 1990s in response to the managed care 
movement and were often based on a targeted length of stay (Lagoe, 1998). 
During this era, Hydo (1995) outlined the process required to design an effective 
stroke clinical pathway. This included physician orders with cues, a daily nursing 
documentation form with a case management plan, and a corresponding patient 
education tool. This pathway was used at a Michigan hospital where the true 
benefit of the clinical pathway at the facility was that it identified areas of process 
improvement and prompted positive changes for stroke care. 
In order to evaluate the impact of implementation of a clinical pathway for 
stroke, both hospital-specific and disease-specific variables should be identified. 
Those criteria or measures identified must be integrated into each stage of a 
pathway in order to produce change. A 1997 study involving the implementation 
of stroke clinical pathways at several hospitals identified the need to individualize 
pathways to capture information for specific variables. Each hospital in the study 
chose clinical pathway variables that met its own quality improvement needs 
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while also agreeing to collect a common set of variables such as length of stay, 
use of resources, and clinical outcomes (Hainsworth, Lockwood-Cook, Pond, & 
Lagoe). A British study explored the effects of an “integrated clinical pathway” in 
a hospital’s acute stroke unit by comparing patient outcomes and care processes 
in an intervention and control group. At the end of the study, quality of 
documentation in the intervention group was significantly improved, a CT scan 
was more likely to be done within 24 and 48 hours, and there was a lower rate of 
urinary tract infection (Kwan, Hand, Dennis, & Sandercock, 2004). 
Bonnono, Criddle, Lutsep, Steven, Kearns & Norton (2000) described the 
use of an ‘emergi-path’ for stroke intended to act as a patient care guide and 
documentation tool for members of the stroke team in the emergent phase of 
stroke. It included outcome goals for the patient and defined what nurses and 
physicians should document in the medical record related to stroke care. The 
emergi-path included orders for the acute evaluation of patients with stroke 
symptom onset of less than 24 hours, as well as instructions for the evaluation of 
thrombolytic eligibility. The goal of the emergi-path was to increase the 
percentage of acute ischemic stroke patients who received intravenous 
thrombolytics within three hours of symptom onset. However, data was not 
provided in the article to suggest if use of the emergi-path resulted in increased 
use of t-PA for stroke at the facility. 
An Australian hospital revised an existing, but underutilized, stroke clinical 
pathway into a more patient-centered documentation form. The pathway included 
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automatic referrals and consultations, which resulted in a decreased average 
length of stay and improved clinical outcomes due to the required involvement of 
specialists (Wilkinson, Parcell, & MacDonald, 2000). The California Acute Stroke 
Pilot Registry (2005) reviewed use of standardized order sets for stroke in a 
number of hospitals. For hospitals using standardized stroke orders, an 
improvement in documentation of deep vein thrombosis (DVT) prophylaxis, lipid-
lowering medications at discharge, and antithrombotics at 48 hours and 
discharge was demonstrated.  
Kwan and Sandercock (2004) conducted a review of in-hospital care 
pathways for stroke for Cochrane Database and concluded there was insufficient 
evidence to support the use of stroke clinical pathways in the acute care and 
rehabilitation settings. The review included three randomized trials and 12 non-
randomized studies and determined there was not a significant difference 
between control groups and pathway groups in comparison of mortality rates or 
discharge destination. It appeared that patients managed with a stroke clinical 
pathway were more dependent at discharge, but less likely to be readmitted. 
They were also less likely to have a urinary tract infection, and more likely to 
have neuroimaging studies. Counter intuitively, the review also suggested 
evidence of a lower rate of patient satisfaction and a lower quality of life with 
clinical-pathway managed stroke patients. This suggests that a stroke clinical 
pathway may not be a panacea for optimal patient outcomes. 
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Examples of physician order sets and clinical pathways for stroke 
management are readily available through a simple internet search. The ASA 
and the Brain Attack Coalition have copies of physician orders and clinical 
pathways for stroke available on their websites from hospitals active in improving 
stroke care. Availability of such forms suggests that use of standard order sets 
and clinical pathways are routinely used in the care of stroke patients across the 
United States. In fact, the ASA specifically recognizes the need for stroke clinical 
pathways and stated such tools should be used consistently in an organization to 
minimize stroke progression and complications (Swhamm, Pancioli, et al., 2005).  
The National Stroke Association hosts a Stroke Center Network electronic 
mailing list where a frequent topic of discussion for stroke care professionals 
seeking information to improve processes at hospitals where they work, is the 
utilization of order sets and pathways that include stroke protocols (National 
Stroke Association, n.d.). Discussions are archived for retrieval by Stroke Center 
Network members.  
 The implementation of a comprehensive stroke clinical pathway may 
improve the use of clinical guidelines for the management of stroke patients. For 
a clinical pathway to do this, it must be designed to fit the needs of a specific 
organization and blend with current documentation practices. One of the major 
obstacles to success of a clinical pathway is lack of use by the multidisciplinary 
team involved in patient care. A restraining force is a lack of investment and 
support by the stroke management team for use of a clinical pathway. To limit 
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barriers to pathway implementation, restraining forces should be minimized and 
driving forces emphasized. It is therefore imperative that a clinical pathway not 
require significant alteration in existing processes for writing orders and 
documenting care at the hospital where it is implemented.  
Stroke Clinical Pathway Development and Implementation 
In 1998, at the hospital for this study, a CareMap® for stroke was 
designed and implemented that was based on an eight day length of stay 
requiring multidisciplinary documentation. A standardized stroke order set was 
implemented in conjunction with the CareMap®. However, use of the pathway 
by physicians, nurses and therapists was limited and the CareMap® was 
eventually abandoned. The physician orders developed for the CareMap® were 
converted into generic stroke admission orders and continue to be used by the 
neurologists. 
In 2006, at the study hospital, a team led by the Director of Nursing for the 
neuroscience unit and the affiliated rehabilitation hospital began implementation 
of a new stroke initiative. This multidisciplinary team was comprised of 
physicians, nurses, therapists, and other disciplines from the emergency, 
neuroscience, radiology, rehabilitation, pharmacy, and nutrition departments. A 
long-term goal for the team was to prepare the hospital for JCAHO Primary 
Stroke Center certification by improving, revising, and refining existing processes 
for the management of stroke patients. Using a collaborative effort, this team 
identified ongoing areas of improvement in the process of stroke care. A 
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comprehensive stroke clinical pathway was one of the needs identified and 
development of the pathway was delegated to the Neuroscience Clinical Nurse 
Educator.   
The stroke clinical pathway was developed to consist of three physician 
order sets for the different phases of hospitalization, an interdisciplinary plan of 
care, and an education/flow sheet which lists topics for patient/family education 
by members of the patient care team. Development of a comprehensive stroke 
clinical pathway required the input and review of all disciplines involved in care 
of a stroke patient.   
Currently, a Stroke Care Team consisting of case management, nursing, 
physical therapy, occupational therapy, speech therapy, and nutrition meets 
twice weekly for multidisciplinary rounds on the neuroscience unit where the plan 
of care for each stroke patient on the unit is discussed. The same therapists see 
stroke patients throughout the hospital and are experts within the facility. This 
multidisciplinary group of professionals participated in the creation of all the 
documents developed for the stroke clinical pathway and provided valuable input 
based on specialty.  
One neurologist, acting as a physician champion for stroke care, was 
closely involved in the development of the physician order sets, multidisciplinary 
documentation forms and patient education handbook. The physician order sets, 
plan of care, and education flow sheet were presented as a “stroke clinical 
pathway” and approved by the Neuroscience Section. The Neuroscience Section 
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membership consists of all neurologists and neurosurgeons with privileges at the 
study hospital and is committed to addressing clinical issues related to care of 
the neuroscience patient.  
 The stroke clinical pathway was designed to improve compliance with the 
ten JCAHO disease-specific measures (Table 2). In addition, the clinical pathway 
forms were developed to meet hospital-defined criteria for documentation as 
follows:   
1. Appropriate for ischemic stroke, hemorrhagic stroke, and TIA 
2. Address stroke patient management in the emergency department, at 
inpatient admission, and upon discharge 
3. Incorporate an interdisciplinary plan of care with interventions and 
outcomes specific to stroke, an anticipated length of stay, and a 
patient version of the care plan 
4.  Include a patient/family education form with identified stroke 
education topics  
 The individual forms of the stroke clinical pathway were approved by all 
hospital-required committees and implemented in April 2006. Each of the 
physician order sets and multidisciplinary forms are available online via the 
hospital intranet and computerized order entry/documentation system. All 
registered nurses on the neuroscience/stroke unit have been educated about the 
stroke clinical pathway and trained in the assessment of stroke patients and are 
certified by the ASA in the use of the National Institute of Health Stroke Scale 
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(the standard assessment tool identified in the stroke clinical pathway). Additional 
education for nurses and therapists was identified and provided at the 
department level as needed. 
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CHAPTER III 
METHODS AND PROCEDURES 
Study Design 
 The ten JCAHO disease-specific criteria identified by JCAHO for stroke 
were the variables of measurement for this study. Compliance rates of 
documentation in the medical record were compared for each of the ten JCAHO 
disease-specific measures before and after stroke clinical pathway 
implementation. Two retrospective chart reviews were conducted to determine 
documentation compliance rates. The first review included 110 stroke patient 
records (baseline data) discharged in the year prior to clinical pathway 
implementation. The second review included 110 stroke patient records six 
months after the implementation date. The compliance rates for each of the ten 
measures were compared from the baseline data to the post-clinical pathway 
implementation data. Comparison of the compliance rates for each measure was 
used to determine if there was statistically significant improvement in the level of 
documentation in the medical record. Comparison of the documentation rates for 
patients with the stroke clinical pathway and those without was also completed. 
Fisher’s Exact test was used to assess differences between the baseline and 
post-intervention rates. Confidence intervals of 95% were calculated for the 
baseline and post-intervention compliance rates. 
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Sample 
JCAHO defined requirements for sample population and size in its 
implementation guide for stroke center certification.  As instructed by the JCAHO 
Performance Measurement Implementation Guide’s (2004) section on sampling 
(Appendix H), 20% of adult stroke admissions were sampled to provide a 
baseline data set.  A query of patients over the age of 18 with stroke ICD-9-CM 
codes identified by JCAHO was performed (Table 3). This query identified 550 
adult stroke patients discharged between the dates of January 1, 2005 and 
December 31, 2005. The hospital’s quality management department chose a 
weighted random sample of 110 charts based on the three categories of stroke. 
There were 334, 114, and 102 total patients in the ischemic stroke, hemorrhagic 
stroke, and TIA population groups, respectively (Table 5). Twenty percent 
samples were taken within each group using random numbers generated through 
an online randomization software program (Research Randomizer, n.d.)  
 
Table 5.  Sampling Numbers for Control Group  
 Total # in Population # in 20% Random Sample  
Ischemic 334 67  
Hemorrhagic 114 23  
TIA 102 20  
Instruments and Data Collection 
 The GWTG-Stroke database, which covers the JCAHO measures, was 
used for data collection. Appendix G includes the JCAHO data collection tool 
from which the GWTG-Stroke Patient Management Tool (PMT) was designed. 
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Data entry training of authorized persons by Outcome Sciences, Inc., the 
administrators of the AHA GWTG-Stroke database, was provided once the tool 
was purchased by the study hospital. The primary data collector was the 
Neuroscience Clinical Nurse Educator. Six other data collectors included nurses 
from the Neuroscience Center and a Clinical Nurse Specialist working within the 
same department.  The compliance rates for measure documentation were 
reported as aggregate data.  
Data Management 
 Patient records were de-identified at the point of data entry into the 
GWTG-Stroke database for confidentiality purposes. The GWTG-Stroke 
database requires a user password and requires assignment of a unique number 
to each patient record. Numbers were assigned 1-110 for the baseline group and 
1001-1110 for the intervention group. A separate cross-reference file with both 
numbers was maintained. The hospital’s quality management department may 
use any demographic information collected within this database. These data 
include age, gender, race, admitting and consulting physician services, 
admission location within the hospital, and utilization of the stroke clinical 
pathway. This information could also be analyzed for trends in the disease-
specific measures related to any of these demographics. The GWTG-Stroke 
database includes basic reports and the hospital’s quality management 
department assisted in analyzing all data results included in this study.  
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 The GWTG-Stroke PMT was used to collect the data for the 220 patients 
in the control and intervention group through medical record review. Data was 
entered from the PMT into the GWTG-Stroke database. Optional fields within the 
database were designated to note the use of each component of the stroke 
clinical pathway for the intervention group. 
Limitations 
 The sampling methods for this study were based on the JCAHO 
Performance Measurement Implementation Guide 2004) to best represent the 
stroke population at the study hospital. Within the intervention group, comparison 
of measure compliance for patients with the clinical pathway present versus 
those without resulted in a smaller sample size within the 110 patient record 
intervention group. Another threat to the validity of the study is in the data 
collection method which utilized six different data abstractors (i.e. inter-rater 
reliability). Although the GTWG-Stroke database has coding instructions for the 
data collector, there remains some ambiguity about how specific the 
documentation must be to meet the performance measure criteria. Efforts to 
reduce inter-rater variability included consultation with a clinical operations 
analyst in the quality management department to clarify the type of 
documentation required to meet the coding requirements. The more ambiguous 
measures were also reviewed by the lead researcher as each record was 
entered into the GWTG-Stroke database.  
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CHAPTER IV 
RESULTS 
 
 This chapter presents the results of the statistical analysis for the control 
group versus the intervention group and within the intervention group, the no 
clinical pathway group versus the clinical pathway group.  Additional evaluation 
of the use of the stroke clinical pathway in relation to specific performance 
measures follows. 
Control Group versus Intervention Group 
 The GWTG-Stroke database is designed to run configured reports for the 
ten JCAHO performance measures. The “JCAHO Pilot-10” report extracts the 
numerator and denominator for each measure as defined by the JCAHO Stroke 
Performance Measurement Implementation Guide from all patient records 
entered into the database. A JCAHO Pilot-10 report was run for the control group 
and the intervention group. The report provided a spreadsheet detail for each 
quality measure. The spreadsheet indicated which patient records were included 
and excluded from the measure criteria and if the measure was met or not met. 
The patient records included for each measure in the intervention group were 
then matched with the corresponding optional field data that indicated which 
element of the stroke clinical pathway was used in the patient record. From this 
information, a final spreadsheet was created to identify, for each patient record, if 
the individual quality measure was met, not met, or excluded. An additional 
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indicator was used for the intervention group to identify use of the stroke clinical 
pathway. 
 The data were then analyzed using SAS v9.0 software (Statistical Analysis 
System, Cary, NC). Compliance rates were compared using Fisher’s Exact test 
and 95% confidence intervals. P-values <0.05 were considered indicative of 
statistical significance. This analysis compared the control and the intervention 
group for compliance with each measure. The same analysis was completed 
within the intervention group to compare the compliance rate for each measure 
for those patients with at least one form of the stroke clinical pathway utilized. 
 Results of documentation compliance for the control group versus 
intervention group are detailed in Table 6 and shown as a graph in Figure 2. 
Statistically significant differences are noted with an asterisk.  
 There were no statistically significant differences between the compliance 
rates for documentation of the following measures: 
• DVT prophylaxis 
• antithrombotic at discharge 
• anticoagulant for atrial fibrillation 
• consideration and administration of t-PA 
• antithrombotic within 48 hours 
• presence of lipid profile 
• dysphagia screening 
• planning for rehabilitation 
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While six patients were potentially eligible, no patients received t-PA in the 
intervention group. The GWTG-Stroke database allows the data collector to infer 
the presence of contraindications to t-PA regardless of specific documentation by 
the physician. Six patients arrived at the study facility’s emergency department 
within 180 minutes of stroke symptom onset as documented in the medical 
record. However, there was insufficient documentation to allow the data 
collectors to infer the precise contraindications apparent to the physician, which 
prohibited t-PA administration. Further analysis of the records for patients 
potentially eligible for thrombolytics would be useful to identify opportunities for 
process improvement. 
 The control group versus the intervention group demonstrated statistically 
significant improvements in the documentation compliance rates for 
patient/family stroke education (p<0.001) and smoking cessation counseling 
(p<0.001). However, the large improvement in the smoking cessation measure 
cannot be attributed to the implementation of the stroke clinical pathway. In 2006, 
the hospital implemented changes in the nursing admission history to meet CMS 
standards for documentation of smoking cessation counseling by prompting the 
nurse to document materials provided to the patient. Those changes were 
sufficient to meet the documentation requirements for the stroke measure. A 
computerized charting system used in the Emergency Department also included 
a notation for smoking cessation counseling and was present in the medical 
records for smokers in both the control and intervention groups. However, the 
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simple notation that smoking cessation counseling was provided did not meet 
measure criteria based on the GWTG-Stroke database coding instructions 
(Stroke Coding Instructions v7.2, 2006). 
 Improvement in documentation of stroke education may be equally 
attributed to the use of the clinical pathway forms as to the process of pathway 
implementation. There was an increase in documentation of stroke education in 
the intervention group even in the absence of the clinical pathway. Nursing, as a 
discipline, most consistently documented patient/family stroke education in the 
medical record. The increased documentation rate in patients without the clinical 
pathway may be attributed to the raised awareness about stroke education and 
resource availability among nurses who had used the pathway with other 
patients, or attended workshops where the clinical pathway was presented. 
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Table 6. Measure Compliance for Control Group vs. Intervention Group 
DSC Stroke 
Measure Group N 
Number 
(%) 
compliant 
Fisher’s 
Exact Test 
p-value 
1 Deep vein thrombosis prophylaxis  
Control 
Intervention 
39 
37 
36 
33
(92.3) 
(89.2) 0.71 
2 Discharged on antithrombotics 
Control 
Intervention 
80 
72 
76 
72
(95.0) 
(100) 0.12 
3 
Patients with atrial 
fibrillation receiving 
anticoagulation therapy 
Control 
Intervention 
7 
12 
7 
11
(100) 
(91.7) 1.00 
4A Tissue plasminogen activator (t-PA) considered 
Control 
Intervention 
12 
15 
7 
10
(58.3) 
(66.7) 0.71 
4B 
Tissue plasminogen 
activator (t-PA) 
administered 
Control 
Intervention 
5 
6 
3 
0 
(60.0) 
(0.0) 0.06 
5 
Antithrombotic medication 
within 48 hours of 
hospitalization 
Control 
Intervention 
72 
71 
70 
67
(97.2) 
(94.4) 0.44 
6 Lipid profile Control Intervention 
85 
76 
49 
55
(57.6) 
(72.4) 0.07 
7 Screen for dysphagia Control Intervention 
84 
68 
31 
27
(36.9) 
(39.7) 0.74 
8 Stroke education Control Intervention 
10
8 
90 
6 
24
(5.6) 
(26.7) <0.001* 
9 Smoking cessation Control Intervention 
26 
21 
8 
19
(30.8) 
(90.5) <0.001* 
10 A plan for rehabilitation was considered 
Control 
Intervention 
88 
70 
75 
64
(85.2) 
(91.4) 0.33 
* Significant at the 0.05 level  
 
38 
Figure 2.  Comparison of Control Group Measures to Intervention Group 
○Control      □ Intervention 
 
 
Items marked with an * indicate statistical significance 
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Intervention Group versus Clinical Pathway Group 
Analyses within the intervention group to determine the influence of stroke 
clinical pathway use on documentation of the ten JCAHO disease-specific 
measures were completed. Thirty-three (30%) of the 110 patients in the 
intervention group had at least one form of the stroke clinical pathway utilized. 
Data analyses within the intervention group comparing documentation 
compliance for patients with the stroke clinical pathway/order sets in use and 
those without are summarized in Table 7 and as a graph Figure 3. Measures with 
statistically significant improvement are noted with an asterisk. There were no 
statistically significant differences in the compliance rates in the following stroke 
performance measures: 
• DVT prophylaxis 
• antithrombotic at discharge 
• anticoagulant for atrial fibrillation 
• consideration and administration of t-PA 
• antithrombotic within 48 hours 
• dysphagia screening 
• smoking cessation counseling 
• planning for rehabilitation  
There was a noticeable difference in the t-PA considered performance 
measure for the clinical pathway group (88.9%) versus the no clinical pathway 
group (33.3%), but it was not statistically significant. It is, however, clinically 
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significant that documentation of consideration for t-PA, the only Food and Drug 
Administration (FDA) approved medication to treat acute stroke, was present in 
the medical record. It is interesting to note that for some patient records, the only 
physician documentation of t-PA consideration was on the Stroke Admission 
Orders.  
One patient record out of five with atrial fibrillation in the clinical pathway 
group did not have documented contraindications to anticoagulation. The Stroke 
Admission order set used for this patient has a medication section containing the 
statement “Anticoagulant for ischemic stroke of cardioembolic source”, but does 
not prompt documentation of contraindications to anticoagulant therapy. The 
Stroke Interdisciplinary Plan of Care has prompts for nursing related to this 
measure, but was not used for this patient. 
 The smoking cessation measure was not met for two patients in the 
clinical pathway group. One patient had only the Emergency Department Orders 
of the clinical pathway in place, which does not address smoking cessation. The 
other patient had all elements of the clinical pathway used except the Stroke 
Admission Orders, most of which include smoking cessation-counseling prompts. 
For this patient, the clinical pathway did not ensure adequate documentation of 
smoking cessation counseling or treatment. The documentation prompts 
embedded in the nursing admission history previously referenced were not 
utilized for either of these two patients. 
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 Two of the stroke performance measures in the intervention group had a 
statistically significant improvement when the stroke clinical pathway was utilized. 
Those measures were patient/family stroke education and lipid profile. 
Over half of the patients with the clinical pathway had patient/family stroke 
education documented. The Stroke Admission Orders include an order for 
patient/family stroke education and was present on 80% of the charts with 
required documentation. Over 50% of the charts with stroke education 
documentation had the Stroke Interdisciplinary Plan of Care and the Stroke 
Interdisciplinary Patient/Education Flow Sheet present in the record. The 
increased rate of compliance with stroke education may be attributed to the 
clinical pathway. Although location of the patient in the hospital was not a 
variable for this study, it is noteworthy that all patients with documentation of 
education on the clinical pathway were admitted or transferred to the 
neuroscience/stroke unit. 
 Two patient records with the clinical pathway utilized did not have lipid 
profile results available. A lipid profile is a pre-checked item on the Stroke 
Admission Orders; therefore, any patient admitted with the order set should have 
had a lipid profile drawn. The Stroke Admission Orders were used for one of the 
patient records, but no results were available. 
42 
 Table 7.   Measure Compliance for No Clinical Pathway Group vs. Clinical 
Pathway Group 
DSC Stroke  
Measure Group N 
Number (%) 
compliant 
Fisher’s 
Exact Test 
p-value 
1 
Deep vein 
thrombosis 
prophylaxis  
No Pathway 
Pathway 
24 
13 
21 
12 
(87.5) 
(92.3) 1.00 
2 Discharged on antithrombotics 
No Pathway 
Pathway 
45 
27 
45 
27 
(100) 
(100) - 
3 
Patients with atrial 
fibrillation receiving 
anticoagulation 
therapy 
No Pathway 
Pathway 
7 
5 
7 
4 
(100) 
(80) 0.42 
4A 
Tissue plasminogen 
activator (t-PA) 
considered 
No Pathway 
Pathway 
6 
9 
2 
8 
(33.3) 
(88.9) 0.09 
4B 
Tissue plasminogen 
activator (t-PA) 
administered 
No Pathway 
Pathway 
4 
2 
0 
0 
(0.0) 
(0.0) - 
5 
Antithrombotic 
medication within 48 
hours of 
hospitalization 
No Pathway 
Pathway 
43 
28 
39 
28 
(90.7) 
(100) 0.15 
6 Lipid profile No Pathway Pathway 
48 
28 
29 
26 
(60.4) 
(92.9) 0.003* 
7 Screen for dysphagia 
No Pathway 
Pathway 
47 
21 
16 
11 
(34.0) 
(52.4) 0.19 
8 Stroke education 
N No 
Pathway 
Pathway 
61 
29 
9 
15 
(14.8) 
(51.7) <0.001* 
9 Smoking cessation No Pathway Pathway 
11 
10 
11 
8 
(100) 
(80) 0.21 
10 
A plan for 
rehabilitation was 
considered 
No Pathway 
Pathway 
47 
23 
41 
23 
(87.2) 
(100) 0.17 
* Significant at the 0.05 level  
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Figure 3.  Comparison of No Clinical Pathway Group Measures to Clinical 
Pathway Group 
○No Pathway     □ Pathway 
Items marked with an * indicate statistical significance 
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Additional Findings 
The form most often used from the stroke clinical pathway was the Stroke 
Admission Orders. This form includes a section directing the admitting nurse to 
initiate the Stroke Interdisciplinary Plan of Care and utilize the Stroke 
Interdisciplinary Patient/Family Education Flow Sheet and Handbook. These 
forms were the second and third most utilized elements of the clinical pathway 
respectively (Table 8). Of the 33 patients with the clinical pathway, 17 had at 
least one element in the pathway present. Only one chart had all stroke clinical 
pathway forms utilized (Table 9). 
 
Table 8.    Number (%) of Each Clinical Pathway Form Present 
Emergency 
Orders 
Admission 
Orders 
Discharge 
Orders 
Interdisciplinary 
Plan of Care 
Interdisciplinary 
Patient/Family 
Education Flow 
Sheet & 
Handbook 
7 
(21.2%) 
26 
(78.8%) 
4 
(12.1%) 
12 
(36.4%) 
11 
(33.3%) 
 
 
Table 9.    Number (%) with Multiple Clinical Pathway Forms Present 
1 Form 2 Forms 3 Forms 4 Forms 5 Forms 
17 
(51.5%) 
7 
(21.2%) 
6 
(18.2%) 
2 
(6.1%) 
1 
(3.0%) 
 
 An analysis of the number of measures met in the control group, 
intervention group, and clinical pathway group was completed to determine if 
there was an increase in the documentation of multiple performance measures 
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for each patient rather than the individual measure only. A Chi-square test for 
linear trend revealed that the increased compliance with multiple measures for 
patients on the clinical pathway was statistically significant (Table 10 & Figure 4). 
The control group and intervention group, as a whole did not show the same 
trend with multiple measures as the clinical pathway group.  
Table 10.   Number (%) of Records with Multiple Measures Met with and 
without Clinical Pathway Forms Present 
Number of 
measures met 
Number of 
records  
Number records (%) 
without Pathway 
Number records (%) 
With Pathway  
0 15 14 (93.3%) 1 (6.7%) 
1-2 21 19 (90.5%) 2 (9.5%) 
3-4 36 27 (75%) 9 (25.0%) 
5-6 26 13 (50.0%) 13 (50.0%) 
7-8 12 4 (33.3%) 8 (66.7%) 
 
 
Figure 4. Graph of Increased Compliance of Measures Met with Clinical 
Pathway Forms Used 
Note: p<0.001 from Chi-square test for linear trend. This indicates a statistically 
significant increase in the # of measures met as the usage 
of clinical pathway increases.                                      
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A factor, which could have affected the study results, was the institution of 
a multidisciplinary Stroke Discharge Team at the hospital. Starting in January 
2007, this team met daily to facilitate discharge plans and notify physicians when 
the stroke clinical pathway was not utilized. The data collected for this study 
included 23 patients admitted after the multidisciplinary stroke team was formed. 
The 23 patients did not show the same trend with documentation of multiple 
measures as did the clinical pathway group. Ideally, however, a clinical pathway 
is a tool used by a multidisciplinary team to promote the use of evidence-based 
medicine and documentation of key quality indicators. 
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CHAPTER V 
DISCUSSION 
 
 The intervention group demonstrated statistically significant improvement 
in the documentation of patient/family stroke education (p<0.001). This positive 
change was also statistically significant in the intervention group when the stroke 
clinical pathway was used (p<0.001). Patient/family education about the type of 
stroke, treatment plan, and risk factor modifications are vital elements of quality 
nursing care. Without education about modifiable risk factors, secondary stroke 
prevention is limited. Thus, nurses play a pivotal role in helping the patient avoid 
a second stroke. The Stroke Admission Orders direct the admitting nurse to 
initiate and document stroke education. The improvement in this measure with 
the use of a clinical pathway demonstrates how nurses effectively utilize a 
physician order set as a checklist.  
 The pre-checked item for a lipid profile in the admission order set also had 
a statistically significant influence on measure compliance (p<0.003). The 
improvement demonstrates that it is useful to force compliance with some orders 
rather than leaving it to the individual physician to make a choice. However, there 
should be thoughtful consideration of which measures to enforce in this manner 
to ensure individualization of patient care. 
 The clinical pathway not only led to improvement in two individual 
measures, it improved the overall compliance with documentation of multiple 
measures. Meeting more performance measures per individual patient is more 
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indicative of quality patient care than improving compliance in only one measure. 
This study suggests that implementation of a clinical pathway can help 
physicians and nurses improve quality measure documentation. 
 Deficiencies in the clinical pathway process may have limited the clinical 
pathway utilization. This may be the reason only 30% of patients in the 
intervention group had any element of the clinical pathway in place. To make the 
clinical pathway more user friendly, it should be simplified into as few documents 
as possible, while not requiring additional effort to initiate. The Emergency 
Department order sets were the second least utilized element of the pathway in 
this study. The Emergency Department at the study facility uses a computerized 
documentation and order entry system. Integrating performance measures into 
that system would facilitate compliance with measures affecting patients entering 
through that department. Customization of any computerized documentation 
system can be a time consuming and costly endeavor, which may prove limiting. 
 The Stroke Discharge Orders were the least utilized component of the 
clinical pathway. While the computer system at the facility was set up to 
automatically print the Discharge Orders, it would only do so if the unit secretary 
selected the “Stroke Admission” packet when the inpatient chart is prepared. If 
the standard admission packet is selected, a generic discharge order form is 
printed and placed on the chart that does not prompt the physician to consider 
discharge quality measures. Computerized physician order entry (CPOE) could 
help ensure discharge stroke measures are met by integrating prompts for 
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patients with a stroke diagnosis. Currently, the study facility is in the initial stages 
of transition to a CPOE system. The hospital’s discharge instructions for nursing 
are already computerized, so inclusion of prompts for patients with stroke 
diagnosis could enhance documentation of stroke performance measures at 
discharge. Since some of the stroke measures at discharge are physician 
initiated, the effectiveness of including prompts in the nursing discharge would be 
limited. 
 While instructions to screen stroke patients for dysphagia were included in 
the Stroke Admission Orders and the Stroke Interdisciplinary Plan of Care, there 
are not specific prompts to ensure documentation of swallow screen by nursing 
in the medical record. Inclusion of such instructions in future revisions of the 
clinical pathway should be considered. Addition of a formal dysphagia screening 
form that is completed by the bedside nurse prior to oral intake may be a useful 
tool to include in the pathway. Such a tool should provide instructions to withhold 
all oral intake for stroke patients with symptoms suspicious for impaired 
swallowing until evaluation by a Speech Pathologist is completed.  
 The study facility currently utilizes a computerized nursing documentation 
system, but it does not include the Interdisciplinary Plan of Care. Use of the 
hospital’s generic Interdisciplinary Plan of Care form is not consistent. Use of the 
Stroke Interdisciplinary Plan of Care was also limited as evidenced by this study. 
Transition to a computerized plan of care could trigger documentation prompts 
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for quality measures based on nurses’ charting. The hospital is investigating this 
type of option. 
 Compliance with the measure of anticoagulant therapy for patients with 
atrial fibrillation was high, but one patient with the clinical pathway did not meet 
the measure criteria. Opportunity to document contraindications to anticoagulant 
therapy in the clinical pathway may have helped with meeting this measure by 
excluding the patient record from the denominator population. The measure for 
consideration of t-PA could also have improved documentation with incorporation 
of a prompt to document contraindications to thrombolytic therapy. These 
additions should be considered with future stroke clinical pathway revisions.  
Conclusions 
A clinical pathway is always a challenge to implement and maintain due to 
the complex nature of patient care. Success depends in part on the level of 
pathway integration into existing documentation processes. Clinical pathways 
have been used in various settings and in multiple formats to improve 
documentation and streamline patient care with reports of mixed success (Kwan, 
Sandercock, 2004).  
The most recently published update to the ASA guidelines for acute 
ischemic stroke management includes a recommendation for use of standardized 
stroke care order sets to improve the general management of stroke patients 
(Adams, Del Zoppo, et al., 2007). This is a new recommendation based on the 
consensus that a clinical pathway is useful despite limited evidence from large 
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trials. This study demonstrates that documentation, which is a reflection of care 
given, can be improved by the incorporation of evidence-based guidelines into a 
clinical pathway consisting of order sets, interdisciplinary care plans, and flow 
sheets.  However, the small number of patients in the intervention/clinical 
pathway group of 33 patients limits the power to detect statistically significant 
differences. Continued surveillance of the effect of the clinical pathway on 
documentation in the study facility with the GWTG-Stroke tool is suggested to 
further explore the relationship between the clinical pathway use and measure 
compliance. Additional research into the subject is recommended on a larger 
scale and in other institutions.  
 Development and implementation of a clinical pathway for stroke care 
must be a multidisciplinary endeavor. While each discipline involved in the care 
of the stroke patient at the study facility was consulted for input into pathway 
development, it was on an individual basis rather than in a group forum. There 
was not sufficient opportunity for the stroke care team to discuss existing 
processes and how the clinical pathway could be utilized at each step in the 
stroke patient’s hospital course. This lack of a comprehensive and ongoing team 
commitment to the development and implementation of the clinical pathway very 
likely reduced its acceptance and utilization. 
Consistent and continuous feedback to physicians and nurses about use 
of the clinical pathway and compliance with quality measures is vital to the 
success of a clinical pathway in influencing care. A designated position such as a 
52 
nurse coordinator to provide concurrent feedback about the clinical pathway to 
the healthcare team would likely have had a positive effect on its use and 
documentation. A multidisciplinary team active in the care of individual stroke 
patients and in program development is necessary to improve compliance with 
quality measures. A database such as GWTG-Stroke to gather data concurrently, 
identify key measures specific to the stroke patient, and provide feedback on 
compliance is a valuable tool for improving stroke care in a hospital. 
Nursing Implications 
 This study has demonstrated that a stroke clinical pathway can have a 
positive effect on documentation of specific quality measures and can increase 
compliance with multiple measures for the individual patient. While the increase 
in smoking cessation counseling cannot be attributed to the stroke clinical 
pathway, it was a direct result of changes in the nursing documentation system, 
similar to intent of the clinical pathway. Improvement in patient/family stroke 
education, however, can be attributed the stroke clinical pathway. Nursing is 
primarily responsible for patient/family education; providing learning resources, 
reminders, and a checklist within the clinical pathway process proved to be 
useful. However, even with the improvement in stroke education, only about one-
fourth of the patients in the intervention group had documented evidence that 
stroke teaching occurred demonstrating there is still much work to be done to 
meet this measure. Providing to each nursing unit involved in care of the stroke 
patient, a compliance chart on a monthly basis may be a way to raise staff 
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awareness of the value of this nursing intervention. The improvement in lipid 
profile measure shows that it is effective to make some quality measures 
mandatory, rather than leaving them to the discretion of the physician. This 
principle would apply to nursing care orders as well.  
 The t-PA administration rates in the intervention group are of particular 
concern and should received special attention. The control group had an overall 
rate of t-PA administration of 4.5%, while the intervention group did not have any 
patients. Individual chart analysis of those who arrived to the hospital’s 
emergency department within three hours of symptom onset, may help in 
identifying specific areas of process improvement for acute stroke evaluation. 
Early identification and work-up of patients eligible for t-PA is vital. The earlier t-
PA is administered, the greater the possibility decreased disability and improved 
outcome. Another measure for closer attention is the dysphagia. Staff education 
focused on the importance of a swallowing evaluation for stroke patients will be 
necessary. Incorporation of a dysphagia screening checklist for the nurse into 
existing documentation systems should also be considered. 
 Unfortunately only 30% of the intervention group records had the stroke 
clinical pathway in place. The lack of pathway acceptance by physicians and 
nurses seriously undermines the potential benefits in quality measure 
improvement. In retrospect, efforts to involve physicians and nurses in the 
emergency department, intensive care unit, and the acute care unit to a much 
greater degree in the development of the pathway could have resulted in a more 
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successful pathway implementation. Staff in each of these departments should 
be actively involved in all pathway revisions and may benefit from participating in 
chart reviews to better identify deficiencies in documentation of quality measures. 
Future research with this data should include further be analysis to identify trends 
in measure compliance based on admitting physicians, consulting physicians, 
and nursing unit as well as demographics such as age, ethnicity, and payor 
source. 
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Stroke Discharge Orders  
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Appendix E 
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Appendix F 
South Carolina Nurses Association Educational Content Objective Form  
   
EDUCATIONAL ACTIVITY 
 
OBJECTIVES CONTENT (Topics) TIME 
FRAME 
PRESE
NTER 
METHODS 
List learner’s objectives 
in behavioral terms 
Provide an outline of the content 
for each objective. It must be 
more than a restatement of the 
objective. 
State the 
time frame 
for each 
objective 
List the 
Faculty 
for each 
objective
.  
Describe the teaching 
methods, strategies, 
materials & resources 
for each objective 
Introduction/Welcome • Pretest Katie 
Woodfin, 
BSN, 
RN 
Pretest form 10 
minutes Introduction of Case 
Study of typical 
stroke patient 
• Introduction of Case Study #1  
 
4:00-
4:10pm 
Didactic 15 
minutes 
4:10 – 
4:25 pm 
Cynthia 
Bishop, 
MSN, 
RN, 
CRRN 
A. Recognize the value 
of JCAHO Stroke 
Center designation and 
clinical pathway in 
ensuring practice of 
evidence based stroke 
care. 
• JCAHO Stroke Center 
designation & stroke unit  
B. Relate symptoms of 
stroke type  
Didactic Lorette 
Mitchem
, MSN, 
ANP 
30 
minutes 
 
4:25pm- 
4:55pm 
    and location of injury. 
 
 
 
Overview of stroke 
• Population affected, statistics, 
risk factors 
Lead group 
discussion to relate 
Case Study #1 
patient symptoms to 
possible type/location 
of stroke 
• Types of stroke & causes 
(ischemic, hemorrhagic, SAH) 
• Arterial distribution & 
correlating stroke symptoms 
in ischemic stroke 
• Type of stroke related to case 
study  
Question/Answer 
opportunity 
C. Discuss the scope of 
emergency 
     department 
management for  
     stroke patients. 
 
 
30 
minutes 
 
4:55pm-
5:25pm 
Martin 
Lutz, 
MD 
Didactic (to include 
Case Study #1 
patient’s ED 
experience) 
 
 
 
ED Management of acute stroke 
• EMS  
• Triage on arrival to ED 
• Symptoms suspicious of 
stroke 
• Assessment 
• Initial diagnostic tests 
Group discussion 
Question/Answer 
opportunity 
 • BP management 
• tPA assessment 
• Case study presentation to 
the ED 
 
76 
 
OBJECTIVES CONTENT (Topics) TIME 
FRAME 
PRESE
NTER 
METHODS 
List learner’s objectives 
in behavioral terms 
Provide an outline of the content 
for each objective. It must be 
more than a restatement of the 
objective. 
State the 
time frame 
for each 
objective 
List learner’s 
objectives in 
behavioral terms 
List the 
Faculty 
for each 
objective
.  
30 
minutes 
 
5:25pm-
5:55pm 
Naveen 
Parti, 
MD 
D. Describe the value 
of radiology  
D. Describe the value of 
radiology  
Imaging for stroke 
• Stat CT: rationale, normal 
findings, abnormal findings. 
• MRI: when, normal vs 
abnormal 
• CTA 
• Angio 
     testing for stroke. 
• Other radiology test 
• Examples of stroke related 
changes seen on radiology 
films  
• Radiology tests applicable to 
case study and possible 
results 
     testing for stroke. 
Break  20 
minutes 
5:55 - 
6:15pm 
 Break 
E. Explain the tests, 
medications,  
    interventions, and risk 
factor  
    modification for acute 
stroke  
    treatment, prevention 
of potential  
    complications and 
second stroke. 
45 
minutes 
 
 
 
 
Acute stroke treatment: 
• TPA administration 
• Rationales and implications 
for diagnostic tests: MRI, 
EKG, Echo, Telemetry, 
Lipids, PT/PTT 
• BP Management 
• Antithrombotics 
• Potential complications:  
     Oxygenation, fever, glucose  
control, DVT prophylaxis 
• Risk factor modification 
• Neurologist admission orders 
 
6:15 – 
7:00 pm 
John 
Absher, 
MD 
E. Explain the tests, 
medications,  
    interventions, and 
risk factor  
    modification for 
acute stroke  
    treatment, 
prevention of 
potential  
 
    complications and 
second stroke. 
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 OBJECTIVES CONTENT (Topics) TIME 
FRAME 
PRESENT
ER 
METHODS 
List learner’s 
objectives in 
behavioral terms 
List the 
Faculty for 
each 
objective.  
Provide an outline of the content 
for each objective. It must be 
more than a restatement of the 
objective. 
State the 
time frame 
for each 
objective 
List learner’s objectives in 
behavioral terms 
 F. Discuss the role of the 
interdisciplinary team in 
treatment of acute stroke 
and case study 
 
 
 
 
 
 
Stroke Team:  
• consideration of 
rehabilitation/discharge needs 
• PT 
 
• OT 
 
 
• Speech Therapy 
 
 
• Nutrition 
 
 
• Case Management 
     discharge of patient 
50 
minutes 
7:00 - 7:50 
7:00 - 
7:10pm 
7:10 - 
7:20pm 
 
7:20 - 
7:30pm 
 
7:30 - 
7:40pm 
 
7:40 - 
7:50pm 
 
 
LouNell 
Eady, PT 
Brigitte 
King, 
OTR/L 
Karen 
Arunakel  
ST 
Jennifer 
Leckenby, 
RD 
Tammy 
Edge, 
BSN, RN 
Didactic (to include 
Case Study #1 
interdisciplinary 
treatment plan) 
Video of swallow 
study 
Question/Answers  
 
Group discussion 
Didactic Patti 
Morgan, 
RN  
 G. Describe the contents 
of GHS’s stroke clinical 
pathway and how it 
relates to external 
agencies guidelines 
Presentation of Case study 
(patient admitted for TIA and  
had a stroke while an inpatient 
and received tPA) 
 
Stroke Clinical Pathway  
• ASA guidelines  
•  JCAHO disease specific 
criteria: 
• ED orders (tPA consideration, 
administration) 
• Admission orders 
• Discharge orders 
• Stroke Interdisciplinary Plan 
of Care 
• Stroke Pt/Family Education 
Flowsheet 
• Stroke Pt/Family Education 
handbook 
 
Post Test & Evaluations 
5 minutes 
7:50 - 7:55 
pm 
 
 
30 
minutes 
7:55 - 8:25 
pm 
 
 
 
 
 
 
 
 
 
 
 
 
5 minutes 
 
 
  
Didactic  
Handouts including 
sample stroke clinical 
pathway 
 
Shannon 
Sternberg, 
BSN, RN, 
CNRN 
8:25 – 
8:30 pm 
Question/Answers 
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JCAHO Stroke Data Collection Tool 
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Appendix H 
JCAHO Stroke Center Certification-Section I: Sampling  
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Appendix I 
IRC Approval Form  
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